Approval · Notice of Compliance 18915 · 2017
NERISONE: Notice of Compliance 18915
Issued January 26, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 18915
- Date
- January 26, 2017
- Company
- Glaxosmithkline IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- To remove all reference to the nerisone cream 0.1% w/w format from the product monograph and package insert following the din discontinuation of the nerisone cream dosage form
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| NERISONE | Not yet assigned | — |
Medicinal ingredients
- DIFLUCORTOLONE VALERATE 0.1 PER